AcuFocus is developing a corneal implant to treat presbyopia (the need for reading glasses).
AlterG is marketing its “G-Trainer” technology, a treadmill system that reduces the users’ body weight/impact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury.
Augmenix has developed an injectable spacer to protect surrounding organs during radiation therapy.
ATI is developing an implantable neuromodulation system for patients suffering from migraines and other severe headaches.
Benvenue Medical is developing and marketing innovative spine repair technology.
Celula is developing rare cell isolation technology for diagnostic and therapeutic purposes.
Ceterix is developing a new orthopedic suturing technology that is focused on improving ease-of-use and operative speed.
ForSight VISION4 is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets.
ForSight Vision 5, Inc. is developing novel ocular drug delivery technologies.
Glaukos is developing an implantable device to treat glaucoma.
GluMetrics, Inc. is a medical device company focused on bringing life-saving continuous glucose monitoring products to the healthcare market.
Halscion is advancing a solution for reduction of surgically induced scarring.
Helical Solutions is developing a novel technology for treatment of atrial fibrillation (AF) with the goal of bringing a simple, safe and effective solution to the treatment of this serious condition.
Novel devices to treat obstructive lung disease. Previously, Innovative Pulmonary Solutions.
ImpediMed is commercializing a bioimpedance spectroscopy (BIS) monitoring system for lymphedema, a complication of cancer that results in limb swelling due to lymphatic blockage.
Intersection Medical is developing a cardiovascular monitoring system for patients with congestive heart failure.
Intuity Medical, formerly Rosedale, is developing a handheld, all in-one discrete, blood-based diagnostic platform that will enhance glucose monitoring for diabetic patients.
Microfabrica has developed a broad micro-scale platform for minimally invasive procedures and for complex dynamic implants.
Minerva is developing next–generation technology for treating excessive menstrual bleeding.
Neurotech Pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases.
Nexis Vision is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets.
Ocular Therapeutix has a novel PEG hydrogel platform technology focused on ocular sealant, wound closure, and drug delivery.
Oculeve is developing a novel treatment for Dry Eye, a disease affecting many millions of people worldwide.
OraMetrix is a leading industry provider of innovative 3-D technology solutions facilitating and improving the quality of orthodontic care.
Respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure.
Rox is developing devices for treatment of diseases of the respiratory system.
Second Sight is developing a prosthetic retinal implant which will return functional vision to patients blinded from retinitis pigmentosa and age-related macular degeneration.
Sequent Medical is developing a novel device for the treatment of cerebral aneurysm.
Transcend Medical is an ophthalmic technology incubator.
Twelve, Inc. is transforming mitral valve replacement.
WaveTec is commercializing an ophthalmic surgical guidance system.
Zyga is developing and marketing innovative, minimally invasive surgical solutions to treat conditions of the spine.